Keyword Connections

multidrug-resistant tuberculosis

Journals

12

1 Scientific reports

2 PloS one

3 Medicine

4 The European respiratory journal

5 BMC infectious diseases

6 revista panamericana de salud publica = pan american journal of public health

7 biometrics

8 the lancet global health

9 Tropical medicine and infectious disease

10 anatomical record (hoboken, nj : 2007)

11 journal of clinical tuberculosis and other mycobacterial diseases

12 erj open research

Research Groups

0

No Research Group Connected

Bibliographies

61

1 Estimating treatment importance in multidrug-resistant tuberculosis using Targeted Learning: An observational individual patient data network meta-analysis.

2 [Loss to follow-up in patients treated for multidrug-resistant tuberculosis in EcuadorA Perda de seguimento de pacientes tratados para tuberculose multirresistente a medicamentos no Equador].

3 Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis.

4 Direct costs of illness of patients with chronic cough in rural Malawi-Experiences from Dowa and Ntchisi districts.

5 Comparison of serum neopterin levels in pulmonary tuberculosis patients with positive acid fast bacilli and inactive pulmonary tuberculosis.

6 Outcomes of Community-Based Systematic Screening of Household Contacts of Patients with Multidrug-Resistant Tuberculosis in Myanmar.

7 Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study.

8 Serum proteins TGFBI, PCSK9, and CCL14 are potential biomarkers for different traditional Chinese medicine syndromes of multidrug-resistant tuberculosis.

9 detection of ofloxacin resistance by nitrate reductase assay in mycobacterium tuberculosis isolates from extrapulmonary tuberculosis

10 prevalence and first-line drug sensitivity trends of mycobacterium tuberculosis at a tertiary center in north-east india

11 impact of drug resistance on the tuberculosis treatment outcome

12 Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients

13 Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China

14 Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China

15 Identifying differentially expressed long non-coding RNAs in PBMCs in response to the infection of multidrug-resistant tuberculosis

16 Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis

17 Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia

18 Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study

19 Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia

20 Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients

21 Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China

22 Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China

23 Identifying differentially expressed long non-coding RNAs in PBMCs in response to the infection of multidrug-resistant tuberculosis

24 Sputum bacteriology conversion and treatment outcome of patients with multidrug-resistant tuberculosis

25 Determinants of multidrug-resistant tuberculosis in Addis Ababa, Ethiopia

26 Risk factors for multidrug-resistant tuberculosis among tuberculosis patients: a case-control study

27 Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia

28 Comparison of Serum Potassium, MagnEsium, and Calcium Levels between Kanamycin and Capreomycin-BASEd Regimen-Treated MultiDrug-Resistant TuBerculosis Patients in Bandung (CEASE MDR-TB): A Retrospective Cohort Study

29 [Control and management strategies in multidrug-resistant tuberculosis: literature reviewEstrategias de control y atención de la tuberculosis multirresistente: una revisión de la literatura].

30 [Multidrug-resistant tuberculosis: A management problem that weighs heavily on the University Hospitals of Strasbourg].

31 Multidrug-resistant tuberculosis.

32 The burden of latent multidrug-resistant tuberculosis.

33 Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling.

34 A nationwide study of multidrug-resistant tuberculosis in Portugal 2014-2017 using epidemiological and molecular clustering analyses.

35 Frequency of the Mycobacterium tuberculosis RD genotype and its association with multidrug-resistant tuberculosis.

36 Multidrug-resistant tuberculosis (MDR-TB): Epidemiology, mechanisms of drug resistance

37 Multidrug-resistant tuberculosis (MDR-TB): Epidemiology, prevention and treatment

38 Análise comparativa entre tuberculose multirresistente e tuberculose extensivamente resistente - Epidemiologia e factores preditivos Comparative analysis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis - Epidemiology and predictive factors

39 Multidrug-resistant tuberculosis

40 [Survival time and influencing factors in multidrug-resistant tuberculosis patients in Wuhan, 2006-2014].

41 Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: Low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation

42 Meta-narrative review of molecular methods for diagnosis and monitoring of multidrug-resistant tuberculosis treatment in adults.

43 Genome sequence of Mycobacterium yongonense RT 955-2015 isolate from a patient misdiagnosed with multidrug-resistant tuberculosis: First clinical detection in Tanzania.

44 Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis.

45 Investigating spillover of multidrug-resistant tuberculosis from a prison: a spatial and molecular epidemiological analysis

46 Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

47 Minimum Inhibitory Concentrations of Fluoroquinolones and Pyrazinamide Susceptibility Correlate to Clinical Improvement in Multidrug-resistant Tuberculosis Patients: A Nationwide Swedish Cohort Study Over 2 Decades

48 applicability of the shorter ‘bangladesh regimen’ in high multidrug-resistant tuberculosis settings

49 the role of process analysis and expert consultation in implementing an electronic medical record solution for multidrug-resistant tuberculosis

50 t cell cytokine responses in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis following stimulation with proteins purified from mycobacterium tuberculosis mdr clinical isolates

51 prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in viet nam, 2011

52 minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: an integrated approach for multidrug-resistant tuberculosis

53 rifabutin: is it useful in the treatment of multidrug-resistant tuberculosis?

54 prevalence of multidrug-resistant tuberculosis and associated factors in ethiopia: a systematic review

55 systematic evaluation of structure-activity relationships of the riminophenazine class and discovery of a c2 pyridylamino series for the treatment of multidrug-resistant tuberculosis

56 possible impact of the standardized category iv regimen on multidrug-resistant tuberculosis patients in mumbai

57 fluoroquinolone resistance in non-multidrug-resistant tuberculosis—a surveillance study in new south wales, australia, and a review of global resistance rates

58 epidemiology and spatial distribution of cases of multidrug-resistant tuberculosis (mdr-tb) in brazil, 2008-2012

59 risk factors for multidrug-resistant tuberculosis

60 Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis

61 [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].